After the successful rollout of Insugen (a low cost human insulin) and on the way to developing oral insulin, Biocon is working on insulin cartridges which can be administered through a reusable pen.
"The insulin pens using Biocon's cartridges will be sourced through FDA-approved manufacturers and are expected to hit the market in 6-9 months," said a senior company official.